John E Gallina
CIK 1433032 · EVP & Chief Financial Officer · last filed 2026-07-07
John E Gallina is an EVP & Chief Financial Officer who has filed 37 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing, for ARAI, was dated Jul 7, 2026. Across all open-market trades the lifetime net is −$36.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $24.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$24.84M
6
37
-$36.30M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARAI | Director | 18,202 | $0.25 | $4.6K | $0 | 6 | 2026-07-07 |
| CVS | Director | 582 | $109.34 | $63.6K | $0 | 2 | 2026-05-15 |
| ELV | EVP & Chief Financial Officer | 63,725 | $385.73 | $24.58M | $0 | 1 | 2023-03-03 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Chief Financial Officer | 46,857 | $482.58 | $22.61M | -$24.09M | 9 | 2022-03-03 |
| ANTX | EVP & Chief Financial Officer | 40,510 | $4.70 | $190.4K | -$5.65M | 6 | 2018-03-07 |
| Elevance Health, Inc. (WLP) Delisted | SVP & Chief Accounting Officer | 22,490 | — | — | -$6.56M | 13 | 2014-03-05 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-07 | ARAI | Grant (A) | — | $0 | EDGAR |
| 2026-05-15 | CVS | Grant (A) | — | $0 | EDGAR |
| 2026-04-02 | ARAI | Grant (A) | — | $0 | EDGAR |
| 2026-03-20 | CVS | Grant (A) | +582 | $41.8K | EDGAR |
| 2026-01-05 | ARAI | Grant (A) | — | $0 | EDGAR |
| 2025-10-20 | ARAI | Grant (A) | — | $0 | EDGAR |
| 2025-10-08 | ARAI | Grant (A) | +7,292 | $0 | EDGAR |
| 2025-09-03 | ARAI | Grant (A) | +8,549 | $0 | EDGAR |
| 2023-03-03 | ELV | Mixed | +7,544 | -$2.46M | EDGAR |
| 2022-03-03 | Elevance Health, Inc. (ANTM) Delisted | Mixed | +5,162 | -$2.07M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.